Amicus Therapeutics' Series D Round

Amicus Therapeutics raised a round of funding on September 08, 2006.

Amicus (NASDQ:FOLD) is a biopharmaceutical company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases.…

Articles about Amicus Therapeutics' Series D Round: